articl
examin
three
aspect
antivir
hydroxychloroquin
chloroquin
remdesvir
might
relat
treatment
viral
infect
use
vapor
deliveri
antivir
bulk
constitu
mild
antivir
efficaci
ii
applic
marin
natur
product
extract
oppos
singl
molecul
antivir
agent
iii
counter
intuit
approach
formul
part
base
deliv
multipl
speci
fall
three
categori
build
block
viru
acceler
replic
energi
sourc
infect
cell
boost
immun
respons
speci
antagon
provid
toxic
viru
bioactiv
vapor
compos
organ
speci
potenti
deliv
pharmaceut
agent
effici
econom
articl
focus
vapor
deliveri
hydroxychloroquin
bryostatin
two
compound
antivir
activ
bioactiv
formul
detail
applic
marin
natur
product
antivir
agent
administr
drug
match
hostspecif
bioactiv
formul
discuss
marin
natur
product
bryostatin
test
collect
molecular
speci
found
natur
singl
activ
structur
vape
deliveri
nicotin
speci
found
vape
juic
tremend
health
risk
howev
similar
devic
could
test
antivir
drug
deliveri
incorpor
bulk
solut
treatment
viral
infect
hydroxychloroquin
chloroquin
antimalari
agent
investig
potenti
treatment
coronaviru
result
sever
acut
respiratori
syndrom
sar
indic
inhal
rout
use
aerosol
vapor
might
offer
effect
treatment
method
compar
pill
iv
implant
assum
drug
deliv
accept
dose
littl
side
effect
formul
consist
three
bulk
constitu
propylen
glycol
glycerin
ethanol
volum
pg
glycerin
ethanol
test
method
deliv
uniqu
set
formul
antiand
provir
activ
glycerin
use
fix
virus
decad
propylen
glycol
shown
inactiv
virus
ethanol
wide
use
viral
disinfect
ethanol
also
ad
increas
solubl
polar
speci
ammonium
chlorid
neg
impact
viral
replic
rate
includ
low
level
fatti
acid
includ
stearic
oleic
linol
andor
arachidon
acid
includ
total
mass
state
l
solubl
fatti
acid
solvent
must
consid
demonstr
specif
fatti
acid
impact
replic
rate
coronaviru
human
serum
albumin
provid
sourc
amino
acid
viru
suspend
solut
ethanol
denatur
structur
allow
decompos
basic
build
block
less
effort
ssdna
ad
build
block
util
viru
two
macromolecul
compris
total
mass
fructos
glucos
includ
energi
sourc
infect
cell
increas
metabol
process
along
uptak
rate
drug
attack
viral
popul
infect
cell
mass
hydroxychloroquin
test
level
high
bulk
solvent
mass
typic
formul
hydroxychloroquin
bryostatin
extract
bulk
solvent
mass
speci
maximum
solvent
mass
hydroxychloroquin
replac
wth
chloroquin
remdesivir
evapor
experi
experi
bulk
solvent
contain
differ
mixtur
propos
antivir
bioactiv
ingredi
vapor
commerci
avail
vape
devic
us
vapor
pull
cm
id
tube
length
l
flask
vacuum
pull
stop
trap
vapor
flask
flask
contain
ml
high
puriti
water
static
vapor
contact
aqueou
phase
vacuum
appli
cycl
perform
five
time
water
remov
analyz
lcm
speci
confirm
use
parent
ion
least
one
fragment
coronaviru
infect
lung
specif
primari
alveolar
epitheli
cell
rapid
respons
cell
immun
system
monosaccharid
provid
addit
local
energi
cell
protein
nucleic
acid
suspend
solvent
provid
build
block
viral
replic
process
goal
maintain
acceler
viral
replic
improv
efficaci
drug
vulner
phase
time
fatti
acid
ethanol
glycerin
provid
antagonist
activ
toward
viru
molecular
level
vapor
process
droplet
compos
glycerin
propylen
glycol
ten
sever
hundr
nanomet
diamet
rang
nanoparticl
rapidli
releas
bioactiv
speci
lung
owe
high
surfacearea
volum
ratio
multitud
agent
potenti
interact
viru
short
timespan
present
uniqu
conundrum
replic
surviv
inhal
approach
enabl
lower
dose
administ
second
pharmaceut
test
marin
natur
product
bryostatin
bryostatin
shown
variou
level
efficaci
differ
type
cancer
neurolog
diseas
antivir
activ
protein
kinas
c
modul
medicin
applic
limit
largescal
studi
cost
avail
bryostatin
natur
produc
marin
bacteria
symbiot
relationship
bryozoan
bugula
neritina
bryostatin
provid
chemic
defens
predat
seek
bugula
larva
although
interact
viral
bacteri
speci
world
ocean
develop
field
estim
marin
virus
outnumb
marin
bacteria
ratio
rang
suggest
marin
bacterium
interact
multipl
viral
speci
would
need
broadspectrum
antivir
defens
surviv
marin
creatur
beluga
whale
bottlenos
dolphin
infect
coronavirus
defens
system
could
involv
symbiot
bacterium
produc
small
molecul
antivir
properti
bryostatin
group
character
bryophan
ring
two
r
group
fig
bryostatin
structur
isol
bugula
publish
differ
r
r
constitu
probabl
mani
variat
bryophan
ring
natur
analysi
marin
extract
complex
mix
structur
correl
bryophan
ring
differ
r
r
structur
simpl
marin
creatur
fire
coral
use
complex
poison
differ
surviv
task
mixtur
note
literatur
sever
group
complex
mixtur
extract
bugula
suggest
bacteri
defens
system
multiprong
system
singl
structur
qsar
calcul
substructur
r
c
r
c
r
oh
r
c
r
oh
r
oh
r
h
r
oh
r
h
r
h
give
rang
physic
valu
lipinski
rule
logp
tpsa
hbond
possibl
etc
biolog
activ
gproteincoupl
receptor
gpcr
ligand
ion
channel
modul
kinas
inhibitor
nuclear
receptor
ligand
proteas
inhibitor
enzym
inhibitor
typic
mani
natur
product
chemist
isol
focu
singl
molecul
medicin
activ
vapor
experi
replac
hydroxychloroquin
bryostatin
extract
found
speci
higher
water
solubl
appear
aqueou
phase
r
oh
r
oh
r
h
r
oh
r
h
r
h
ester
bond
link
r
r
bryophan
ring
expos
numer
structur
bryophan
ring
r
c
r
c
function
group
natur
occur
carboxyl
marin
environ
complet
preliminari
work
standard
vape
instrument
use
worldwid
deliveri
nicotin
vapor
form
indic
technolog
avail
larg
econom
scale
condit
work
well
understood
typic
use
two
primari
fluid
vapor
process
glycerin
glycerol
c
h
propylen
glycol
c
h
use
studi
preliminari
stage
goal
show
vape
equip
could
use
transport
variou
speci
vapor
flask
despit
minimum
exposur
time
variou
speci
measur
aqueou
phase
group
develop
complex
treat
differ
form
tuberculosi
firstand
secondlin
antibiot
repurpos
attack
microb
addit
antagonist
cu
ii
acceler
cellular
process
energi
sourc
use
similar
repurpos
approach
cancer
drug
use
sucros
glucos
provid
addit
energi
cancer
cell
copper
increas
concentr
limit
nutrient
angiogenesi
process
inclus
fatti
acid
protein
provid
nutrient
increas
serum
lifetim
also
explor
oceancent
synthesi
bryostatin
explor
mani
chemic
reaction
possibl
environ
interdisciplinari
activ
enabl
us
explor
nontradit
approach
econom
often
effici
independ
vitro
studi
